Natural Biocon (India) Limited has postponed its Board of Directors meeting originally scheduled for November 14, 2026. The meeting has been rescheduled to Tuesday, November 24, 2026.

The primary purpose of the board meeting is to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2026.

The postponement was necessitated due to additional time required for completion of certain financial reporting and pending audit-related matters.

Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct for Prevention of Insider Trading, the trading window for dealing in the company's equity shares remains closed. The trading window closure period began on September 30, 2026 and will continue until 48 hours after the declaration of financial results for the quarter and half year ending September 30, 2026.

This intimation is made to BSE Limited and The Calcutta Stock Exchange Limited under Regulation 29(1)(a) of the SEBI Listing Regulations.

The communication is digitally signed by Chaitali Maheshbhai Doshi, Director (DIN: 11930754) of Natural Biocon (India) Limited.